IRCCS Humanitas Research Hospital
IRCCS Humanitas Research Hospital
Rozzano, Milano, Italy8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab. | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Not stated | 2026-09-21 | NCT07330245 | |
| Safety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by Lumpectomy | Breast Neoplasm Malignant Female; Mastectomy, Segmental | Active, not recruiting | Not applicable | 2026-07-22 | NCT05941299 | |
| REPROton-HN: Prospective Observational Study on Proton Re-irradiation for Locoregional Recurrences of Head and Neck Tumors | Head and Neck Neoplasms, Neoplasms by Site, neoplasm | Recruiting | Not stated | 2026-06-09 | NCT07635641 | |
| Nutritional Supplementation to Improve Colorectal Cancer Surgery | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Not yet recruiting | Not applicable | 2026-05-20 | NCT07599501 | |
| Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2026-02-12 | NCT07401615 | |
| Prospective Double Arm Randomized Trial: WBRT Alone and WBRT Plus Silibinin | Neoplasms by Site, brain disorder, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder | Active, not recruiting | Not applicable | 2025-04-24 | NCT05793489 | |
| Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With a PD-L1 Combined Positive Score (CPS)≥1≤19. | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 2 | 2025-03-14 | NCT06869473 | |
| Transcatheter Treatment of Tricuspid Valve Regurgitation | Symptomatic Severe Tricuspid Regurgitation | Not yet recruiting | Not applicable | 2023-10-23 | NCT06093828 |